Role of biochemical markers in assessment of osteoporosis.
作者信息
Riggs B L, Khosla S
机构信息
Division of Endocrinology, Mayo Clinic, Rochester, MN 55905, USA.
出版信息
Acta Orthop Scand Suppl. 1995 Oct;266:14-8.
PMID:8553844
Abstract
摘要
相似文献
1
Role of biochemical markers in assessment of osteoporosis.
Acta Orthop Scand Suppl. 1995 Oct;266:14-8.
2
Biochemical markers of bone turnover in osteoporosis.骨质疏松症中骨转换的生化标志物。
Rev Rhum Engl Ed. 1997 Jun 30;64(6 Suppl):31S-36S.
3
[Biochemical markers of bone turnover for treatment of osteoporosis].
Nihon Rinsho. 2002 Mar;60 Suppl 3:256-62.
4
[The significance of bone biochemical markers and its application for clinics].
Nihon Rinsho. 2004 Feb;62 Suppl 2:333-8.
5
Assessment of four biochemical markers of bone metabolism in postmenopausal osteoporosis.绝经后骨质疏松症中四种骨代谢生化标志物的评估
Clin Lab. 2002;48(7-8):407-13.
6
[Biochemical markers of bone turnover : clinical usefulness in osteoporosis].[骨转换的生化标志物：在骨质疏松症中的临床应用]
Ann Biol Clin (Paris). 1999 Mar-Apr;57(2):137-48.
7
Changes in biochemical parameters of bone turnover and bone mineral density in post-pregnancy osteoporosis.
Am J Obstet Gynecol. 2001 Jul;185(1):246-7. doi: 10.1067/mob.2001.113910.
8
[Biochemical markers of bone in steroid (glucocorticoid)-induced osteoporosis (GIOP)].[类固醇（糖皮质激素）诱导的骨质疏松症（GIOP）中的骨生化标志物]
Clin Calcium. 2006 Nov;16(11):1823-32.
9
Management of osteoporosis.
Adv Intern Med. 1999;44:175-207.
10
Effects of chronic liver disease on bone mineral density and bone metabolism markers in postmenopausal women.慢性肝病对绝经后女性骨密度和骨代谢标志物的影响。
Eur J Obstet Gynecol Reprod Biol. 2005 Nov 1;123(1):67-71. doi: 10.1016/j.ejogrb.2005.06.025. Epub 2005 Jul 26.
引用本文的文献
1
Evaluation of a topical herbal agent for the promotion of bone healing.评价一种促进骨愈合的局部草药制剂。
Evid Based Complement Alternat Med. 2015;2015:905270. doi: 10.1155/2015/905270. Epub 2015 Feb 25.
Zotero 插件